Gene variants at FTO, 9p21, and 2q36.3 are age-independently associated with myocardial infarction in Czech men
Jaroslav A. Hubáček(Institute of Clinical and Experimental Medicine), Jan Piťha(Institute of Clinical and Experimental Medicine), Gabriela Dostálová(Charles University), M Gebauerová(Institute of Clinical and Experimental Medicine), Dana Dlouhá(Centre of Civil Engineering (Czechia)), Aleš Linhart(Charles University), Michal Vrablı́k(Charles University), Libor Vı́tek(Charles University), Věra Adámková(Institute of Clinical and Experimental Medicine), V. Staněk(Institute of Clinical and Experimental Medicine), R Češka(Charles University)
Cited by 20
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|713
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
|New England Journal of Medicine|2014|712